Results 191 to 200 of about 531,069 (346)
Pediatric Blood &Cancer, Volume 73, Issue 2, February 2026.ABSTRACT Purpose Infants with cancer are rare and face unique challenges. Our study aims to describe the incidence of infantile cancers in Canada and to compare treatment‐related mortality (TRM) and their outcomes with those of older children. Methods We conducted a retrospective cohort study using the Cancer in Young People in Canada database ...
Samuel Sassine +22 more
wiley +1 more source
Pediatric Blood &Cancer, Volume 73, Issue 2, February 2026.ABSTRACT Background Patients with solid tumours or lymphomas have an increased risk of thromboembolism (TE) and thrombocytopenia. Evidence‐based strategies for anticoagulation therapy (ACT) for patients with thrombocytopenia are limited. We examined the impact of thrombocytopenia on ACT administration and bleeding incidence in children with solid ...
Andrés Felipe Fajardo +5 more
wiley +1 more source
RNA-Seq reveals the existence of a CDKN1C-E2F1-TP53 axis that is altered in human T-cell lymphoblastic lymphomas [PDF]
, 2018 Pilar López‐Nieva +13 more
openalex +1 more source
Lymphoma Prevalence Patterns in Uganda, 1969-2006
Middle East Journal of Cancer, 2013 Background: Lymphomas are a complex group of malignancies that requireadvanced technology for proper classification. Unfortunately Uganda, as with numerousother Sub-Saharan African countries, lacks these resources.
Adriane Kamulegeya, Louis Muwazi
doaj
Cancer Medicine, Volume 15, Issue 2, February 2026.ABSTRACT Purpose To determine whether adolescent and young adults (AYA) with Hodgkin lymphoma (HL) who are treated by oncologists with “AYA expertise” improve outcomes. Methods All AYA aged 15–21 years diagnosed with HL in Ontario, Canada between 1992 and 2012 were identified, and clinical data abstracted as part of the IMPACT cohort.
Eden C. Andrew +5 more
wiley +1 more source
[New progress in the treatment of T-lymphoblastic lymphoma].
, 2018 Haotian Wang, Cangchun Liu, Li Liu
openalex +2 more sources
Cancer Medicine, Volume 15, Issue 2, February 2026.ABSTRACT Background To evaluate trends in allogeneic hematopoietic cell transplant (HCT) referral perceptions and practices, we compared surveys of Hematology‐Oncology (Hem‐Onc) physicians conducted in 2015 (N = 150), 2019 (N = 302), and 2024 (N = 183) and reported changes over time.
Aye Mon Thida +7 more
wiley +1 more source